Overview
Andrew Duncombe practices practicing medicine in Southampton, United Kingdom.
Mr. Duncombe is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Myelofibrosis, Chronic Lymphocytic Leukemia (CLL), and Essential Thrombocythemia.
He is actively involved in clinical research, co-authoring 43 peer reviewed articles and participating in 1 clinical trial.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Frequently Asked Questions about Andrew S. Duncombe
Is Andrew S. Duncombe a top-rated expert for Myeloproliferative Neoplasms (MPN)?
MediFind is an objective health platform that identifies experts based on real-world data. Andrew S. Duncombe is classified as an Distinguished expert for Myeloproliferative Neoplasms (MPN), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Andrew S. Duncombe participate in research or clinical trials?
Yes. Andrew S. Duncombe has published 43 articles and abstracts on conditions like Myeloproliferative Neoplasms (MPN). You can view a list of Andrew S. Duncombe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Myeloproliferative Neoplasms (MPN)Mr. Duncombe isDistinguished. Learn about Myeloproliferative Neoplasms (MPN).
- Advanced
- Chronic Lymphocytic Leukemia (CLL)Mr. Duncombe isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- MyelofibrosisMr. Duncombe isAdvanced. Learn about Myelofibrosis.
- Experienced
- Blood ClotsMr. Duncombe isExperienced. Learn about Blood Clots.
- Chronic B-Cell Leukemia (CBCL)Mr. Duncombe isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic PolyradiculoneuritisMr. Duncombe isExperienced. Learn about Chronic Polyradiculoneuritis.
- COVID-19Mr. Duncombe isExperienced. Learn about COVID-19.
- Essential ThrombocythemiaMr. Duncombe isExperienced. Learn about Essential Thrombocythemia.
- Hemophagocytic LymphohistiocytosisMr. Duncombe isExperienced. Learn about Hemophagocytic Lymphohistiocytosis.
- HistiocytosisMr. Duncombe isExperienced. Learn about Histiocytosis.
- LeukemiaMr. Duncombe isExperienced. Learn about Leukemia.
- Non-Langerhans-Cell HistiocytosisMr. Duncombe isExperienced. Learn about Non-Langerhans-Cell Histiocytosis.
- Polycythemia VeraMr. Duncombe isExperienced. Learn about Polycythemia Vera.
- ReticulohistiocytomaMr. Duncombe isExperienced. Learn about Reticulohistiocytoma.
- Severe Acute Respiratory Syndrome (SARS)Mr. Duncombe isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).
- Small Lymphocytic Lymphoma (SLL)Mr. Duncombe isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).